Question:
How does Type 1 NSTEMI differ from Type 2 NSTEMI?
Answer:
Type 2 NSTEMI differs significantly from a Type 1 NSTEMI in both its cause and treatment. While a Type 1 NSTEMI results from plaque rupture and thrombus (clot) formation within a coronary artery and is considered an acute coronary syndrome (ACS), a Type 2 NSTEMI occurs because of an imbalance between myocardial oxygen supply and demand. This imbalance is typically secondary to another medical condition, such as sepsis, severe anemia, respiratory failure, arrhythmias, or hypotension, and may occur with or without significant underlying coronary artery disease. Consequently, treatment for a Type 1 NSTEMI often includes antiplatelet therapy, anticoagulation, and possible percutaneous coronary intervention (PCI), whereas management of a Type 2 NSTEMI focuses on identifying and correcting the underlying cause of the supply-demand mismatch.
From a documentation perspective, providers should clearly state “Type 2 MI” or “Type II MI” and identify the underlying condition responsible for the event, such as “Type 2 MI due to acute blood loss anemia” or “Type 2 MI secondary to sepsis.” Documentation should also include evidence of myocardial ischemia along with elevated cardiac troponin levels. For coding purposes, Type 2 MI is reported with ICD-10-CM code I21.A1 (Myocardial infarction type 2). In addition, coders should assign codes for the underlying condition that caused the oxygen supply-demand imbalance, such as sepsis, anemia, or respiratory failure.
